Cerulean raises $35M in follow-on

Oncology company Cerulean Pharma Inc. (NASDAQ:CERU) raised $35 million through the sale of 5.8 million shares at $6 in a follow-on underwritten by Leerink; Barclays; Canaccord Genuity; JMP Securities;...